a public good project by the
Synthesis
Company
of California

© 2026

Martin Rowe | doi.page

0 works0 citations0 h-index

Martin Rowe

Publications by Year

Research Areas

Viral-associated cancers and disorders, Lymphoma Diagnosis and Treatment, Cytomegalovirus and herpesvirus research, Immune Cell Function and Interaction, Parvovirus B19 Infection Studies

Most-Cited Works

→ Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell death(1991)1,187 cited
→ Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics(2012)909 cited
→ Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells.(1987)723 cited
→ Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease(1991)707 cited
→ Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death.(1993)601 cited
→ Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23(1990)575 cited

→ Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.(1992)506 cited

The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain.(1995)

→ Expression of Epstein‐Barr virus‐encoded proteins in nasopharyngeal carcinoma(1988)443 cited

→ Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.(1987)392 cited